PRESS RELEASE published on 07/07/2025 at 14:00, 4 months 29 days ago Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence Salix launches 'I Wish I Knew' campaign for Xifaxan, FDA-approved for hepatic encephalopathy. Advocating patient empowerment and education XIFAXAN FDA-approved Hepatic Encephalopathy Salix I Wish I Knew
BRIEF published on 07/02/2025 at 13:05, 5 months 3 days ago Bausch Health publiera ses résultats financiers du deuxième trimestre 2025 Conférence Téléphonique Annonce Financière Relations Avec Les Investisseurs Bausch Santé Résultats Du Deuxième Trimestre 2025
BRIEF published on 07/02/2025 at 13:05, 5 months 3 days ago Bausch Health to Release Q2 2025 Financial Results Conference Call Investor Relations Financial Announcement Bausch Health Q2 2025 Results
PRESS RELEASE published on 07/02/2025 at 13:00, 5 months 3 days ago Bausch Health to Announce Second Quarter 2025 Results on July 30 Bausch Health Companies Inc. to release Q2 2025 financial results on July 30, 2025, followed by a conference call and webcast at 5:00 p.m. U.S. EDT. Details and materials available on the investor relations website Financial Results Conference Call Investor Relations Webcast Bausch Health
BRIEF published on 05/14/2025 at 22:20, 6 months 21 days ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
BRIEF published on 05/14/2025 at 22:20, 6 months 21 days ago Bausch Health annonce les résultats des élections et les approbations lors de son assemblée annuelle 2025 Bausch Santé Vote Des Actionnaires Élection Du Directeur Assemblée Annuelle Approbation De L'indemnisation
PRESS RELEASE published on 05/14/2025 at 22:15, 6 months 21 days ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 6 months 30 days ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 6 months 30 days ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
PRESS RELEASE published on 05/06/2025 at 14:00, 6 months 30 days ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
Published on 12/05/2025 at 20:25, 44 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 54 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 19 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 49 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 24 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 2 hours 11 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 53 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 23 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 10 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
